Nath Bio-Genes (India) Limited — Others, 22-08-2025: Shareholders meeting

Nath Bio-Genes (India) Limited held its 32nd Annual General Meeting via video conferencing, where shareholders approved all seven proposed resolutions. Key approvals include adopting the audited financial statements for the year, declaring a final dividend of ₹2 per equity share, and re-appointing Mrs. Jeevanlata Kagliwal as a Director. Shareholders also approved the appointment of a Secretarial Auditor for five years, Ms. Payal Jain as an Independent Director, and the re-appointment of Mr. Vadla Nagabhushanam and Mr. Madhukar Deshpande as Independent Directors for their second five-year terms.